These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 16940831)

  • 21. Measles, mumps and rubella infections and atopic disorders in MMR-unvaccinated and MMR-vaccinated children.
    Bernsen RM; van der Wouden JC
    Pediatr Allergy Immunol; 2008 Sep; 19(6):544-51. PubMed ID: 18266826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community cohort study of Cryptosporidium parvum infections: sex-differential incidences associated with BCG and diphtheria-tetanus-pertussis vaccinations.
    Valentiner-Branth P; Perch M; Nielsen J; Steinsland H; Garly ML; Fischer TK; Sommerfelt H; Mølbak K; Aaby P
    Vaccine; 2007 Mar; 25(14):2733-41. PubMed ID: 16513227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau.
    Veirum JE; Sodemann M; Biai S; Jakobsen M; Garly ML; Hedegaard K; Jensen H; Aaby P
    Vaccine; 2005 Jan; 23(9):1197-204. PubMed ID: 15629363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium.
    Theeten H; Vandermeulen C; Roelants M; Hoppenbrouwers K; Depoorter AM; Van Damme P
    Acta Paediatr; 2009 Aug; 98(8):1307-12. PubMed ID: 19432835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia.
    Uno Y; Uchiyama T; Kurosawa M; Aleksic B; Ozaki N
    Vaccine; 2012 Jun; 30(28):4292-8. PubMed ID: 22521285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lack of association between MMR vaccination and the incidence of autism in children: a case-control study].
    Mrozek-Budzyn D; Kiełtyka A; Majewska R
    Przegl Epidemiol; 2009; 63(1):107-12. PubMed ID: 19522237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diphtheria-tetanus-pertussis vaccine and serious neurologic illness: an updated review of the epidemiologic evidence.
    Wentz KR; Marcuse EK
    Pediatrics; 1991 Mar; 87(3):287-97. PubMed ID: 2000268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-specific changes in the female-male mortality ratio related to the pattern of vaccinations: an observational study from rural Gambia.
    Aaby P; Jensen H; Walraven G
    Vaccine; 2006 May; 24(22):4701-8. PubMed ID: 16621182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents.
    O'Leary ST; Glanz JM; McClure DL; Akhtar A; Daley MF; Nakasato C; Baxter R; Davis RL; Izurieta HS; Lieu TA; Ball R
    Pediatrics; 2012 Feb; 129(2):248-55. PubMed ID: 22232308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of serious neurologic disease after immunization of young children in Britain and Ireland.
    Ward KN; Bryant NJ; Andrews NJ; Bowley JS; Ohrling A; Verity CM; Ross EM; Miller E
    Pediatrics; 2007 Aug; 120(2):314-21. PubMed ID: 17671057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
    Andrews N; Miller E; Grant A; Stowe J; Osborne V; Taylor B
    Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No epidemiological evidence for infant vaccinations to cause allergic disease.
    Koppen S; de Groot R; Neijens HJ; Nagelkerke N; van Eden W; Rümke HC
    Vaccine; 2004 Sep; 22(25-26):3375-85. PubMed ID: 15308362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-Bissau.
    Aaby P; Biai S; Veirum JE; Sodemann M; Lisse I; Garly ML; Ravn H; Benn CS; Rodrigues A
    Vaccine; 2007 Jan; 25(7):1265-9. PubMed ID: 17092614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom.
    Miller E; Andrews N; Stowe J; Grant A; Waight P; Taylor B
    Am J Epidemiol; 2007 Mar; 165(6):704-9. PubMed ID: 17204517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccinations, infections and antibacterials in the first grass pollen season of life and risk of later hayfever.
    Bremner SA; Carey IM; DeWilde S; Richards N; Maier WC; Hilton SR; Strachan DP; Cook DG
    Clin Exp Allergy; 2007 Apr; 37(4):512-7. PubMed ID: 17430347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization.
    Klein NP; Hansen J; Lewis E; Lyon L; Nguyen B; Black S; Weston WM; Wu S; Li P; Howe B; Friedland LR
    Pediatr Infect Dis J; 2010 Jul; 29(7):613-7. PubMed ID: 20190673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study.
    Gale JL; Thapa PB; Wassilak SG; Bobo JK; Mendelman PM; Foy HM
    JAMA; 1994 Jan; 271(1):37-41. PubMed ID: 7903109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy.
    Marin M; Nguyen HQ; Langidrik JR; Edwards R; Briand K; Papania MJ; Seward JF; LeBaron CW
    Clin Infect Dis; 2006 Feb; 42(3):315-9. PubMed ID: 16392073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.